The correct questions and the use of appropriate methodology allowed distinguishing MS from NMOSD, in addition to elucidating the cellular and molecular mechanisms, such as seropositive AQP4-specific antibodies, complement participation, encephalitogenic T cell, neutrophil and cytokine crosstalk in the lesions. The gene discussed is AQP4; the disease is myeloid sarcoma.